Structural Protein News and Research

RSS
Scientists show how T cells may help protect against severe COVID

Scientists show how T cells may help protect against severe COVID

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

SARS-CoV-2 detected using smartphone biosensor

SARS-CoV-2 detected using smartphone biosensor

The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

SARS-CoV-2 is evolving adaptively in multiple regions of the genome

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

Study evaluates interactions between SARS-CoV-2 proteins and viral and host RNA

How does the non-structural protein 1 affect COVID-19 pathogenicity?

How does the non-structural protein 1 affect COVID-19 pathogenicity?

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Study models SARS-CoV-2 M protein monomer and dimer 3D structures

Study models SARS-CoV-2 M protein monomer and dimer 3D structures

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

Intragenomic rearrangements help explain how SARS-CoV-2 variants arise

Intragenomic rearrangements help explain how SARS-CoV-2 variants arise

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

Lower exosome component 2 expression protects against clinical SARS-CoV-2 infection

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

SARS-CoV-2 protein interactions with viral and host RNAs in authentic virus-infected cells

SARS-CoV-2 protein interactions with viral and host RNAs in authentic virus-infected cells

A study on the evolution of avian coronavirus escape mutants in vitro

A study on the evolution of avian coronavirus escape mutants in vitro

Will Omicron BA.2 become the next dominant variant?

Will Omicron BA.2 become the next dominant variant?

Gradual decline in pathogenicity and enhanced cytokine induction in SARS-CoV-2 variants

Gradual decline in pathogenicity and enhanced cytokine induction in SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.